Please assess the completion status of the following clinical trial:

Trial Title: PPI And Food Effect Study For PF-06463922 In Healthy Volunteers

Study Design Characteristics:
- Allocation: None
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy female subjects of non-childbearing potential and/or male subjects~* Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight \>50 kg (110 lbs).~* Evidence of a personally signed and dated informed consent document.~* Subject must be willing to avoid direct sunlight exposure or any high intensity ultraviolet light exposure~Exclusion Criteria:~* Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular~* Any condition possibly affecting drug absorption~* A positive urine drug screen.~* Use of tobacco- or nicotine containing products within 90 days of screening or a positive urine cotinine test and history of regular alcohol consumption exceeding 14 drinks/week for females or 21 drinks/week for males within 6 months of Screening.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- PF-06463922 (Type: EXPERIMENTAL): each subject will receive four single doses of PF-06463922 without food, with food, with rabeprazole (without food), and one of the two new formulations without food.

Based on this trial design, predict the completion outcome and termination type (if applicable).